Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 |
Net sales | ||||
Gross profit | -2.00 | 256.57 | 370.72 | 240.85 |
Employee benefit expenses | - 151.60 | - 241.32 | - 252.89 | |
EBIT | -2.00 | 104.97 | 129.40 | -12.04 |
Other financial expenses | -0.06 | -1.05 | -1.81 | |
Pre-tax profit | -2.00 | 104.91 | 128.35 | -13.84 |
Income taxes | -23.03 | -30.09 | 2.15 | |
Net earnings | -2.00 | 81.87 | 98.27 | -11.70 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Tangible assets total | |||||
Other receivables | 30.00 | 30.00 | 30.00 | ||
Investments total | 30.00 | 30.00 | 30.00 | ||
Long term receivables total | |||||
Inventories total | |||||
Current trade debtors | 46.08 | 49.28 | 31.65 | ||
Current other receivables | 40.00 | 29.96 | |||
Current deferred tax assets | 3.15 | ||||
Short term receivables total | 40.00 | 46.08 | 79.23 | 34.79 | |
Cash and bank deposits | 0.00 | 79.51 | 87.02 | 96.97 | |
Cash and cash equivalents | 0.00 | 79.51 | 87.02 | 96.97 | |
Balance sheet total (assets) | 0.00 | 40.00 | 155.59 | 196.25 | 161.76 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 0.00 | 40.00 | 40.00 | 40.00 | 40.00 |
Shares repurchased | 77.00 | 98.27 | |||
Retained earnings | -81.48 | -97.87 | 0.40 | ||
Profit of the financial year | -2.00 | 81.87 | 98.27 | -11.70 | |
Shareholders equity total | 0.00 | 38.00 | 117.40 | 138.66 | 28.70 |
Non-current liabilities total | |||||
Current trade creditors | 2.00 | ||||
Current owed to participating | 1.14 | 0.05 | |||
Short-term deferred tax liabilities | 23.03 | 30.09 | |||
Other non-interest bearing current liabilities | 14.02 | 27.50 | 133.01 | ||
Current liabilities total | 2.00 | 38.20 | 57.59 | 133.06 | |
Balance sheet total (liabilities) | 0.00 | 40.00 | 155.59 | 196.25 | 161.76 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.